Market Overview

Dan Nathan Sees Unusual Options Activity In XBI

Related XBI
Analysis: White House Takes Bully Pulpit Approach On Drug Pricing Reform, Congress Unlikely To Act
'Right To Try' Law Signed By Trump Increases Patient Access To Experimental Drugs
FDA Ad Com Wednesday on molecular targets in pediatric cancer (Seeking Alpha)

On CNBC's "Options Action", Dan Nathan spoke about unusually high options activity in SPDR S&P Biotech (ETF) (NYSE: XBI). He said the put options volume in the name was two times the average daily volume.

When the stock was trading at $86, a trader sold to close 3,000 contracts of the January 86 puts for $1.62 and bought to open 3,000 contracts of the January 83 puts for $0.50. The trade breaks even at $82.50 or 3.29 percent below the closing price Monday.

Posted-In: CNBC Dan Nathan Options ActionSector ETFs Options Markets Media ETFs


Related Articles (XBI)

View Comments and Join the Discussion!